T

Tempus AI Inc
NASDAQ:TEM

Watchlist Manager
Tempus AI Inc
NASDAQ:TEM
Watchlist
Price: 58.6 USD 11.66% Market Closed
Market Cap: 9.2B USD
Have any thoughts about
Tempus AI Inc?
Write Note

Tempus AI Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tempus AI Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
T
Tempus AI Inc
NASDAQ:TEM
Pre-Tax Income
-$213.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Pre-Tax Income
$6.8B
CAGR 3-Years
-12%
CAGR 5-Years
11%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Pre-Tax Income
$4.1B
CAGR 3-Years
-17%
CAGR 5-Years
7%
CAGR 10-Years
2%
Mettler-Toledo International Inc
NYSE:MTD
Pre-Tax Income
$955.2m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
8%
Agilent Technologies Inc
NYSE:A
Pre-Tax Income
$1.5B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Pre-Tax Income
$1.5B
CAGR 3-Years
17%
CAGR 5-Years
33%
CAGR 10-Years
12%
No Stocks Found

Tempus AI Inc
Glance View

Market Cap
9B USD
Industry
Life Sciences Tools & Services

Tempus AI Inc. is revolutionizing the landscape of healthcare by leveraging cutting-edge artificial intelligence to enhance patient care and outcomes. Founded in 2015, the company has focused on integrating advanced data analytics and machine learning technologies to curate personalized treatment plans in oncology and beyond. Their innovative platform aggregates clinical and molecular data, allowing healthcare professionals to make informed decisions based on the latest research and patient-specific information. By partnering with leading healthcare institutions, Tempus is transforming the way physicians approach diagnosis and treatment, ultimately driving a more precise and effective healthcare system. For investors, Tempus represents a compelling opportunity in the rapidly growing health tech sector, especially as demands for personalized medicine continue to rise. The company's robust technology, combined with a strong leadership team and strategic partnerships, positions it as a frontrunner in data-driven healthcare solutions. Tempus has already demonstrated significant traction, evidenced by its expanding clientele and investment from prominent venture capital firms. With a commitment to enhancing patient outcomes and reducing healthcare costs, Tempus AI Inc. is not only shaping the future of medicine but also presenting a promising opportunity for those looking to invest in the intersection of technology and health.

TEM Intrinsic Value
47.39 USD
Overvaluation 19%
Intrinsic Value
Price
T

See Also

What is Tempus AI Inc's Pre-Tax Income?
Pre-Tax Income
-213.8m USD

Based on the financial report for Dec 31, 2023, Tempus AI Inc's Pre-Tax Income amounts to -213.8m USD.

What is Tempus AI Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 1Y
26%

Over the last year, the Pre-Tax Income growth was 26%.

Back to Top